A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures

Journal of Neuro-Oncology

Volumn 99, Issue 2, 2010, Pages 251-260

  Usery, Justin B ^a,b   Michael II, L Madison ^a,c   Sills, Allen K ^d,e   Finch, Christopher K ^a,b  

^a METHODIST UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Brain tumor; Levetiracetam; Neurosurgery; Seizures

Indexed keywords

DEXAMETHASONE; ETIRACETAM; FENTANYL; PARACETAMOL; PHENYTOIN;

ADULT; AGED; BRAIN TUMOR; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; COMPLEX PARTIAL SEIZURE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GLIOBLASTOMA; HEADACHE; HUMAN; INSOMNIA; MALE; MONOTHERAPY; NAUSEA AND VOMITING; NEUROSURGERY; PROSPECTIVE STUDY; RECOMMENDED DRUG DOSE; REVIEW; SCORING SYSTEM; SEIZURE; SOMNOLENCE; TONIC CLONIC SEIZURE;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICONVULSANTS; BRAIN NEOPLASMS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PIRACETAM; PROSPECTIVE STUDIES; SEIZURES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77956059973     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0126-8     Document Type: Review

References (30)

1. Central Brain Tumor Registry of the United States (2007-08) CBTRUS, Chicago
2. JB Posner 1992 Management of brain metastases Rev Neurol (Paris) 148 477 487 1:STN:280:DyaK3s%2FnvFCqtw%3D%3D
3. SH Landis T Murray S Bolden PA Wingo 1999 Cancer statistics, 1999 CA Cancer J Clin 49 8 31 10.3322/canjclin.49.1.8 1:STN:280:DyaK1M3hs1OrsA%3D%3D 10200775
4. FG Davis V Kupelian S Freels B McCarthy T Surawicz 2001 Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups Neuro-Oncology 3 3 152 158 1:STN:280:DC%2BD38%2Fit1GhtQ%3D%3D 11465395
5. JG Villemure N de Tribolet 1996 Epilepsy in patients with central nervous system tumors Curr Opin Neurol 9 6 424 428 10.1097/00019052-199612000-00005 1:STN:280:DyaK2s7lvFyrsQ%3D%3D 9007399
6. Wen P (1997) The diagnosis and management of patients with brain tumors. In: Loeffler JS, Black PM (eds) Cancer of the nervous system. Blackwell Scientific, Boston, pp 106-127
7. PL Moots RJ Maciunas DR Eisert RA Parker K Laporte B Abou-Khalil 1995 The course of seizure disorders in patients with malignant gliomas Arch Neurol 52 717 724 1:STN:280:DyaK2MzksVensg%3D%3D 7619029
8. HJ Mamon PY Wen AC Burns JS Loeffler 1999 Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy Epilepsia 40 341 344 10.1111/j.1528-1157.1999.tb00715.x 1:STN:280: DyaK1M7nvVKjsw%3D%3D 10080516
9. MS Mahaley L Dudka 1981 The role of anticonvulsant medications in the management of patients with anaplastic gliomas Surg Neurol 16 399 401 10.1016/0090-3019(81)90227-5 7330758
10. NA Hagen C Cirrincione HT Thaler, et al. 1990 The role of radiation therapy following resection of single brain metastasis from melanoma Neurology 40 158 160 1:STN:280:DyaK3c7hsVKmtQ%3D%3D 2296364
11. S Hung S Hilsenbeck L Feun 1999 Seizure prophylaxis with phenytoin in patients with brain metastases Proc Am Soc Clin Oncol 10 A1151
12. PL Moots RJ Maciunas DR Eisert, et al. 1995 The course of seizure disorders in patients with malignant gliomas Arch Neurol 52 717 724 1:STN:280:DyaK2MzksVensg%3D%3D 7619029
13. MJ Glantz BF Cole MH Friedberg, et al. 1996 A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors Neurology 46 985 991 1:STN:280:DyaK28zntlOrtA%3D%3D 8780077
14. PA Forsyth S Weaver D Fulton, et al. 2003 Prophylactic anticonvulsants in patients with brain tumour Can J Neurol Sci 30 2 89 90
15. KE VanLandingham RA Radtke 2002 Use of levetiracetam in patients with brain tumors and intractable partial epilepsy Epilepsia 43 7 202
16. F Siddiqui P Wen B Dworetzky D Cabello EB Broomfield 2002 Use of levetiracetam in patients with brain tumors Epilepsia 43 7 297
17. PE Penovich DL Dickens JR Gates, et al. 2004 Treating seizures due to brain neoplasms: rational new choices Epilepsia 45 7 311
18. SE Larson JI Sirven JF Drazkowski RS Zimmerman 2004 Efficacy and tolerability of levetiracetam in patients with brain tumors and seizures Epilepsia 45 7 124
19. GHJ Stevens MA Vogelbaum JH Suh DM Peereboom GH Barnett 2005 Levetiracetam use in brain tumor patients Neurology 64 1 A47 A48
20. J Brandt M Spencer M Folstein 1988 The telephone interview for cognitive status Neuropsychiatr, Neuropsychol Behav Neurol 1 2 111 117
21. L Ferrucci I Del Lungo JM Guralnik, et al. 1998 Is the telephone interview for cognitive status a valid alternative in persons who cannot be evaluated by the mini mental state examination? Aging 10 4 332 338 1:STN:280:DyaK1M%2Fkt1CltA%3D%3D 9825025
22. AM Naidech KT Kreiter N Janjua, et al. 2005 Phenytoin exposure is associated with functional and cognitive disability after subarachnoid hemorrhage Stroke 36 583 587 10.1161/01.STR.0000141936.36596.1e 1:CAS:528:DC%2BD2MXhtl2murw%3D 15662039
23. CE Sanchez CS Ogilvy BS Carter 2007 Outcomes studies in cerebrovascular neurosurgery Neurosurg Focus 22 3 1 21 10.3171/foc.2007.22.3.13
24. JP Valeriano CL Lane 2005 Clinical experience with levetiracetam monotherapy in the treatment of epilepsy Epilepsia 46 8 191
25. HB Newton SA Goldlust D Pearl 2006 Retrospective analysis of the efficacy and tolerability of levetiracetam in brain tumor patients J Neurooncol 78 1 99 102 10.1007/s11060-005-9070-4 1:CAS:528:DC%2BD28XotFeit7k%3D 16541329
26. HB Newton J Dalton S Goldlust D Pearl 2007 Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors J Neurooncol 84 3 293 296 10.1007/s11060-007-9373-8 1:CAS:528: DC%2BD2sXhtVWqtr%2FP 17431542
27. S Rüegg Y Naegelin M Hardmeier DT Winkler S Marsch P Fuhr 2008 Intravenous levetiracetam: treatment experience with the first 50 critically ill patients Epilepsy Behav 12 477 480 10.1016/j.yebeh.2008.01.004 18291724
28. EF Chang MB Potts GE Keles, et al. 2008 Seizure characteristics and control following resection in 332 patients with low-grade gliomas J Neurosurg 108 227 235 10.3171/JNS/2008/108/2/0227 18240916
29. TA Milligan S Hurwitz EB Bromfield 2008 Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery Neurology 71 665 669 10.1212/01.wnl.0000324624.52935.46 1:CAS:528:DC%2BD1cXpvFygtbw%3D 18725591
30. DA Lim P Tarapore E Chang, et al. 2009 Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study J Neurooncol 93 3 349 354 10.1007/s11060-008-9781-4 1:CAS:528:DC%2BD1MXmsVClsb4%3D 19169651